Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 5 days ago

Aura Biosciences, Inc.: MONTANOVA CAPITAL, LLC amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Montanova Capital, LLC amended its Schedule 13G filing with the SEC (accession 0000919574-26-007763) covering its stake in Aura Biosciences, Inc. The amendment updates the investment firm's previously reported beneficial ownership position in the clinical-stage oncology company. Schedule 13G filings are required of investors holding more than 5% of a registered class and are typically amended when holdings change or on the annual deadline. The filing signals a shift in Montanova's position, though the headline disclosure did not specify the revised share count or percentage. Investors will watch for the detailed ownership figures in the amended filing and any subsequent 13G or 13D updates for further changes in the institutional holder base.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

MONTANOVA CAPITAL, LLC, Aura Biosciences, Inc.